Optimisation of the Management of Patients with Coronary Heart Disease and Type 2 Diabetes Mellitus

By Wilson S.H.   Kennedy F.P.   Garratt K.N.  

Drugs & Aging, Vol. 18, Iss. 5, 2001-01 ,pp. : 325-333

Adis International

Access to resources Recommend Favorite

Pharmacologic Prevention of Microvascular and Macrovascular Complications in Diabetes Mellitus: Implications of the Results of Recent Clinical Trials in Type 2 Diabetes

By Tandon Nikhil  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 1, 2012-02 ,pp. : 7-22

Adis International

Access to resources Recommend Favorite

Influence of Intensive versus Conventional Glucose Control on Microvascular and Macrovascular Complications in Type 1 and 2 Diabetes Mellitus

By Mattila Taina K.   >  

Drugs, Vol. 70, Iss. 17, 2010-12 ,pp. : 2229-2245

Adis International

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna  

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

By Britton M.E.   denver A.E.   Mohamed-Ali V.   Yudkin J.S.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite